EMS-Chemie posted Q1 2026 net sales of CHF 487 million, a 6.6% decline versus CHF 522 million a year earlier.
The 7.3 percentage‑point currency headwind from a stronger Swiss franc erased volume gains, though underlying sales volumes rose YoY in both divisions.
High‑Performance Polymers sales fell 6.4% to CHF 439 million; Specialty Chemicals fell 8.1% to CHF 48 million, both hit by the currency drag.
EMS expects 2026 net sales below prior year due to currency effects, while EBIT should be slightly higher than last year.